| Dr Michelle Afkhami, MD | |
|
1500 Duarte Rd, Duarte, CA 91010-3012 | |
| (310) 748-0337 | |
| Not Available |
| Full Name | Dr Michelle Afkhami |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 24 Years |
| Location | 1500 Duarte Rd, Duarte, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326230228 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Of Hope Medical Foundation | 3779751656 | 686 |
News Archive
The revolution in how physicians will be paid brings unique challenges to cancer care, where individual patient needs may make costs hard to predict.
What if your doctor could tell you in real-time, with a non-invasive test as to whether or not you might be having an acute myocardial infarction (AMI) or in simpler terms, a heart attack?
Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.
Diffusion Pharmaceuticals LLC today announced completion of enrollment in a Phase II clinical trial of trans sodium crocetinate, its lead compound for the treatment of cancer.
A large prospective multicenter study headed by Prof. Paul Emmelkamp (Amsterdam), published in the current issue of Psychotherapy and Psychosomatics, unravels new promising data on the psychotherapeutic treatment of severe personality disturbances.
› Verified 3 days ago
| Entity Name | City Of Hope Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244 |
News Archive
The revolution in how physicians will be paid brings unique challenges to cancer care, where individual patient needs may make costs hard to predict.
What if your doctor could tell you in real-time, with a non-invasive test as to whether or not you might be having an acute myocardial infarction (AMI) or in simpler terms, a heart attack?
Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.
Diffusion Pharmaceuticals LLC today announced completion of enrollment in a Phase II clinical trial of trans sodium crocetinate, its lead compound for the treatment of cancer.
A large prospective multicenter study headed by Prof. Paul Emmelkamp (Amsterdam), published in the current issue of Psychotherapy and Psychosomatics, unravels new promising data on the psychotherapeutic treatment of severe personality disturbances.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Afkhami, MD Po Box 512185, Los Angeles, CA 90051-0185 Ph: () - | Dr Michelle Afkhami, MD 1500 Duarte Rd, Duarte, CA 91010-3012 Ph: (310) 748-0337 |
News Archive
The revolution in how physicians will be paid brings unique challenges to cancer care, where individual patient needs may make costs hard to predict.
What if your doctor could tell you in real-time, with a non-invasive test as to whether or not you might be having an acute myocardial infarction (AMI) or in simpler terms, a heart attack?
Scientists have shown in multiple contexts that DNA damage over our lifetimes is a key mechanism behind the development of cancer and other age-related diseases. Not everyone gets these diseases, because the body has multiple mechanisms for repairing the damage caused to DNA by aging, the environment and other human behaviors - but the mechanisms behind certain kinds of DNA repair have not been well-understood.
Diffusion Pharmaceuticals LLC today announced completion of enrollment in a Phase II clinical trial of trans sodium crocetinate, its lead compound for the treatment of cancer.
A large prospective multicenter study headed by Prof. Paul Emmelkamp (Amsterdam), published in the current issue of Psychotherapy and Psychosomatics, unravels new promising data on the psychotherapeutic treatment of severe personality disturbances.
› Verified 3 days ago
Mr. Young Kim, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Winston Yuhsien Lee, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Bharat Nathwani, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Dr. Jing Zhai, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 | |
Dr. Daniel Benedict Schmolze, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 626-256-4673 | |
Fei Fei, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1500 Duarte Rd, Duarte, CA 91010 Phone: 800-826-4673 | |
Dr. Juan-sebastian Saldivar, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1500 E Duarte Rd, Duarte, CA 91010 Phone: 626-359-8111 |